Core Viewpoint - Brain Dynamics Aurora-B (06681) has announced its participation in a significant national science and technology project focused on the prevention and treatment of diseases such as cancer, cardiovascular, respiratory, and metabolic diseases, specifically targeting cognitive disorders related to intracranial atherosclerosis [2][5]. Group 1 - The company's stock price increased by 6.62%, currently trading at 6.28 HKD with a transaction volume of 34.81 million HKD [2][5]. - The project, titled "Establishment of Key Technologies for Digital Diagnosis and Treatment of Cognitive Disorders Related to Intracranial Atherosclerosis," has officially commenced [2][5]. - The project aims to develop a comprehensive assessment technology system and deep reasoning predictive model for cognitive disorders associated with intracranial atherosclerosis, providing tools for early disease screening, risk assessment, prevention, and intervention [2][5]. Group 2 - The establishment of the "Beijing Key Laboratory for Digital Medical Treatment of Cognitive Disorders," in collaboration with Capital Medical University Xuanwu Hospital, has also been officially approved [2][5]. - The project leverages interdisciplinary advantages to conduct systematic research on the diagnostic challenges of cognitive disorders related to ICAS [2][5]. - The initiative will create a closed-loop management system for cognitive disorders associated with ICAS [2][5].
脑动极光-B早盘涨超6% 认知障碍数字医疗北京市重点实验室近日获批成立